DeepMed Research

HOAG MEMORIAL HOSPITAL PRESBYTERIAN

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1952-01-01

Employees: -

Market Cap: -

Website: http://www.hoag.org/Pages/Home.aspx

Clinical Trials

Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma

Phase 2

Withdrawn

Conditions: Lymphoma

First Posted Date: 2004-08-05

Last Posted Date: 2015-08-19

Lead Sponsor: Hoag Memorial Hospital Presbyterian

Registration Number: NCT00004039

Locations: 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

Phase 2

Withdrawn

Conditions: Leukemia
Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2004-08-05

Last Posted Date: 2015-08-19

Lead Sponsor: Hoag Memorial Hospital Presbyterian

Registration Number: NCT00004040

Locations: 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸
Baptist Regional Cancer Center - Knoxville, Knoxville, Tennessee, United States
🇺🇸
St. Joseph Regional Cancer Center, Bryan, Texas, United States

Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma

Phase 2

Withdrawn

Conditions: Lymphoma

First Posted Date: 2004-08-04

Last Posted Date: 2015-08-19

Lead Sponsor: Hoag Memorial Hospital Presbyterian

Registration Number: NCT00003605

Locations: 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸
Bloomington Hospital, Bloomington, Indiana, United States
🇺🇸
St. Joseph Regional Cancer Center, Bryan, Texas, United States

Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma

Phase 2

Withdrawn

Conditions: Lymphoma

First Posted Date: 2004-08-04

Last Posted Date: 2015-08-19

Lead Sponsor: Hoag Memorial Hospital Presbyterian

Registration Number: NCT00003663

Locations: 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸
Cancer Care Center for Southern Indiana, Bloomington, Indiana, United States
🇺🇸
St. Joseph Regional Cancer Center, Bryan, Texas, United States

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

Phase 2

Completed

Conditions: Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Precancerous/Nonmalignant Condition
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-07-26

Last Posted Date: 2011-05-12

Lead Sponsor: Hoag Memorial Hospital Presbyterian

Registration Number: NCT00002504

Locations: 🇺🇸
Bergan Mercy Medical Center, Omaha, Nebraska, United States
🇺🇸
Baptist Regional Cancer Center - Knoxville, Knoxville, Tennessee, United States
🇺🇸
Bloomington Hospital, Bloomington, Indiana, United States

and more 2 locations

Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer

Phase 2

Completed

Conditions: Cervical Cancer
Esophageal Cancer
Head and Neck Cancer
Lung Cancer
Non-melanomatous Skin Cancer
Penile Cancer

First Posted Date: 2004-07-26

Last Posted Date: 2011-05-12

Lead Sponsor: Hoag Memorial Hospital Presbyterian

Registration Number: NCT00002506

Locations: 🇺🇸
Bloomington Hospital, Bloomington, Indiana, United States
🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸
St. Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States

and more 3 locations

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

Phase 2

Completed

Conditions: Kidney Cancer
Melanoma (Skin)

First Posted Date: 2004-07-07

Last Posted Date: 2011-05-12

Lead Sponsor: Hoag Memorial Hospital Presbyterian

Target Recruit Count: 40

Registration Number: NCT00003091

Locations: 🇺🇸
Baptist Regional Cancer Center - Knoxville, Knoxville, Tennessee, United States
🇺🇸
St. Joseph Regional Cancer Center, Bryan, Texas, United States
🇺🇸
Bloomington Hospital, Bloomington, Indiana, United States

and more 1 locations

Biological Therapy in Treating Patients With Metastatic Cancer

Phase 2

Completed

Conditions: Kidney Cancer
Melanoma (Skin)
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-07-01

Last Posted Date: 2011-05-11

Lead Sponsor: Hoag Memorial Hospital Presbyterian

Target Recruit Count: 30

Registration Number: NCT00002733

Locations: 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

Tumor Cell Vaccine in Treating Patients With Advanced Cancer

Phase 2

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-06-28

Last Posted Date: 2011-05-12

Lead Sponsor: Hoag Memorial Hospital Presbyterian

Registration Number: NCT00002505

Locations: 🇺🇸
Bergan Mercy Medical Center, Omaha, Nebraska, United States
🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸
Bloomington Hospital, Bloomington, Indiana, United States

and more 1 locations

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

Phase 2

Completed

Conditions: Leukemia
Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2011-05-12

Lead Sponsor: Hoag Memorial Hospital Presbyterian

Registration Number: NCT00049413

Locations: 🇺🇸
Hoag Cancer Center at Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy